Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranilast for treatment of COVID-19 pneumonia
ChiCTR2000030002Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranilast in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Cure rate. Started Feb 2020; status: recruiting.
02
Drugs
tranilast
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000030002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030002.